Stop wasting time on manual entry and start making faster, smarter decisions with accurate, up-to-date MRNA numbers you can trust.
Download now and get the data you need to stay ahead.
Moderna is a biotechnology company that specializes in the development of mRNA (messenger RNA) technology to create innovative medicines and vaccines. The company gained significant recognition for its rapid development of a COVID-19 vaccine, which was one of the first to receive emergency use authorization globally. Moderna’s focus extends beyond vaccines; it aims to leverage its mRNA platform to develop treatments for various diseases, including infectious diseases, cancer, and rare genetic disorders.
Lavina Talukdar currently serves as the Senior Vice President and Head of Investor Relations at Moderna. She has held this position since April 2019 and has extensive experience in investment management, particularly in the healthcare sector. Her role involves communicating with investors and stakeholders about Moderna’s financial health, strategic direction, and developments in its product pipeline.
For inquiries related to investor relations, you can contact Lavina Talukdar at:
Email: Lavina.Talukdar@modernatx.com
Phone: 617-209-5834
Additionally, general investor inquiries can be directed to the email address: ir@modernatx.com
Moderna has executed one stock split in its history. On July 22, 2010, the company conducted a 1-for-4 reverse stock split, meaning for every four shares held, shareholders received one share.
Investors can find a wealth of information on Moderna’s official investor relations website at investors.modernatx.com. This site includes details about financial results, upcoming events, press releases, and other relevant investor information.
Create a free account to access up to 5 free data sheets.
Daloopa is your gateway to the latest data during earnings, including KPIs, guidance, GAAP to Non-GAAP and more, all formatted for immediate use.
Are you ready to stop wasting time on manual entry and start making faster, smarter decisions with accurate, up-to-date numbers you can trust? Create your free account today and get the data you need to stay ahead.
We believe that AI technology can improve clarity and efficiency for investors and financial markets.
Daloopa was formed in 2019, inspired by our founders’ personal experience at Point72, a NYC- based/short equiy hedge. Accurate data is central to all investment decisions and can influence speed and confidence for decision-makers. We believe that institutional finance has an opportunity to embrace tech-driven accuracy and speed.